Back to Market Feed

Historical record - last NADAC effective date: 5/22/2019

Product Information

DICLOFENAC-MISOPROST 50-200 TB is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $1.7947 per EA under NDC 65162043603. Its NADAC has been published 94 times since Aug 9, 2017.

FDA first approved this application on Nov 25, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DICLOFENAC-MISOPROST 50-200 TB

Diclofenac Sodium and Misoprostol
$1.7947per EA

Strength

50; 200 mg/1; ug/1

NDC

65162043603

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Effective Date

5/22/2019

Approval Type

Generic (ANDA)

FDA Application

ANDA203995

FDA Approved

11/25/2016

TE Code

AB

On Market Since

12/1/2016

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Decreased Prostaglandin Production
Nonsteroidal Anti-inflammatory Drug
Prostaglandin E1 Analog
Prostaglandins E
Synthetic

Price Statistics

The NADAC for DICLOFENAC-MISOPROST 50-200 TB has been published 94 times since Aug 9, 2017, and over the history we have for it it has declined 17.9%. The table below summarizes its recorded NADAC range and movement.

Current price$1.7947 per EA
All-time high$2.1865 (Aug 16, 2017)
All-time low$1.6388 (Jan 23, 2019)
Median price$1.8359
Average price$1.8735
Largest weekly change+20.7% (Feb 20, 2019)
Weeks tracked94
Tracking sinceAug 9, 2017

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-17.9%

Last surveyed May 22, 2019 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 63% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 63%

3 alternatives • Same active ingredient

DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET
Generic
00591039719•Actavis Pharma, Inc.
$0.6645
Save 63%
DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET
Generic
65162043606•Amneal Pharmaceuticals LLC
$0.6645
Save 63%
DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET
Generic
68001023106•BluePoint Laboratories
$0.6645
Save 63%

Related Drugs

Same classification

MINIPRIN EC 81 MG TABLET
Generic
49483033010•Time-Cap Labs Inc.
$0.0118
per EA
MINIPRIN EC 81 MG TABLET
Generic
49483033012•Time-Cap Labs Inc.
$0.0118
per EA
QC ASPIRIN 325 MG TABLET
Generic
63868035203•Chain Drug Marketing Association
$0.0121
per EA
QC ASPIRIN 325 MG TABLET
Generic
63868035210•Chain Drug Marketing Association
$0.0121
per EA
ST. JOSEPH ASPIRIN EC 81 MG TB
Generic
69536018112•Foundation Consumer Healthcare LLC
$0.0139
per EA
ASPIRIN EC 81 MG TABLET
Generic
00536123441•Rugby Laboratories
$0.0142
per EA
ASPIRIN EC 81 MG TABLET
Generic
00904675180•Major Pharmaceuticals
$0.0142
per EA
ASPIRIN EC 81 MG TABLET
Generic
00904678370•Major Pharmaceuticals
$0.0142
per EA
GNP ASPIRIN EC 81 MG TABLET
Generic
46122059848•AmerisourceBergen
$0.0142
per EA
GNP ASPIRIN EC 81 MG TABLET
Generic
46122059887•AmerisourceBergen
$0.0142
per EA

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Manufacturer

Amneal Pharmaceuticals LLC manufacturer profile

See the full portfolio, pricing trend, and other products from this labeler.

Drug market

Diclofenac Sodium and Misoprostol market comparison

Compare this molecule across participating manufacturers and inspect the broader market price spread.

Therapeutic class

Nonsteroidal Anti-inflammatory Drug class view

See how this drug behaves alongside other products in the same FDA pharmacologic class.

Trend hub

Latest market trends

Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.

Guide

Understanding NADAC pricing

Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.

Frequently asked questions

What is the NADAC price of DICLOFENAC-MISOPROST 50-200 TB?

The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC-MISOPROST 50-200 TB, manufactured by Amneal Pharmaceuticals LLC, is $1.7947 per EA (NDC 65162043603), effective May 22, 2019.

How has the price of DICLOFENAC-MISOPROST 50-200 TB changed over time?

Over the history we have for it, the NADAC for DICLOFENAC-MISOPROST 50-200 TB has declined 17.9%. It has been tracked across 94 weekly CMS publications since Aug 9, 2017.

What are the highest and lowest recorded NADAC prices for DICLOFENAC-MISOPROST 50-200 TB?

Since Aug 9, 2017, the NADAC for DICLOFENAC-MISOPROST 50-200 TB has ranged from a low of $1.6388 (Jan 23, 2019) to a high of $2.1865 (Aug 16, 2017), with a median of $1.8359 per EA.

Are there cheaper alternatives to DICLOFENAC-MISOPROST 50-200 TB?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET, is $0.6645 per EA — about 63% below DICLOFENAC-MISOPROST 50-200 TB.

Who manufactures DICLOFENAC-MISOPROST 50-200 TB?

DICLOFENAC-MISOPROST 50-200 TB (NDC 65162043603) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.